We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$2.14B
AUM Growth
+$218M
Cap. Flow
+$189M
Cap. Flow %
8.84%
Top 10 Hldgs %
26.01%
Holding
154
New
13
Increased
61
Reduced
17
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 41.77%
2 Technology 21.44%
3 Consumer Discretionary 12.18%
4 Industrials 9.62%
5 Utilities 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$17.3B
$87.1M 4.08%
1,332,540
XPO icon
2
XPO
XPO
$21.8B
$80.2M 3.76%
2,278,418
COLL icon
3
Collegium Pharmaceutical
COLL
$767M
$56.4M 2.64%
2,207,610
AVXS
4
DELISTED
AveXis, Inc. Common Stock
AVXS
$52M 2.44%
421,000
AIMT
5
DELISTED
Aimmune Therapeutics
AIMT
$49.8M 2.33%
1,564,983
+338,983
+28% +$11.9M
LOW icon
6
Lowe's Companies
LOW
$111B
$49.6M 2.32%
565,000
BLUE
7
DELISTED
bluebird bio
BLUE
$47.4M 2.22%
21,431
LRCX icon
8
Lam Research
LRCX
$394B
$46.1M 2.16%
2,270,000
SPLK
9
DELISTED
Splunk Inc
SPLK
$44.6M 2.09%
453,000
+122,000
+37% +$11.6M
ABBV icon
10
AbbVie
ABBV
$440B
$42.3M 1.98%
447,000
W icon
11
Wayfair
W
$13.5B
$42.3M 1.98%
626,000
SAGE
12
DELISTED
Sage Therapeutics
SAGE
$40.3M 1.89%
250,000
+65,400
+35% +$11.1M
INST
13
DELISTED
Instructure, Inc.
INST
$39.7M 1.86%
942,000
+100,000
+12% +$3.94M
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$132B
$39.6M 1.85%
243,000
+63,000
+35% +$10.3M
MIC
15
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$38.1M 1.78%
1,032,000
+294,900
+40% +$15.9M
HUBS icon
16
HubSpot
HUBS
$11.7B
$37.9M 1.77%
350,000
+142,000
+68% +$14.8M
WCN
17
Waste Connections
WCN
$40.5B
$37.1M 1.74%
517,000
MGA icon
18
Magna International
MGA
$17.6B
$34.9M 1.63%
618,500
+8,500
+1% +$475K
LEA icon
19
Lear
LEA
$6.3B
$34.2M 1.6%
184,000
WBC
20
DELISTED
WABCO HOLDINGS INC.
WBC
$34.2M 1.6%
255,600
ASML icon
21
ASML
ASML
$667B
$34.2M 1.6%
172,000
CCI icon
22
Crown Castle
CCI
$32.1B
$33.4M 1.57%
305,000
STLD icon
23
Steel Dynamics
STLD
$34.9B
$33.3M 1.56%
754,000
-117,000
-13% -$5.39M
OPLN
24
Openlane
OPLN
$4.26B
$33.1M 1.55%
1,611,620
CELG
25
DELISTED
Celgene Corp
CELG
$32.2M 1.51%
361,000
+86,700
+32% +$8.32M

Similar funds

Eventide Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Eventide Asset Management held 154 positions worth $2.14B, up 11% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $189M of net new capital in Q1 2018, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Arista Networks: 1,056,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Trade Desk, an estimated $16.9M trimmed.

  • Eventide Asset Management's largest Q1 2018 buy was Arista Networks: 1,056,000 shares worth $16.9M.
  • Eventide Asset Management added most to GTT Communications, Inc. in Q1 2018, an estimated $19.7M increase.
  • Eventide Asset Management's biggest Q1 2018 reduction was Trade Desk, cutting an estimated $16.9M.
  • Eventide Asset Management fully exited Protagonist Therapeutics in Q1 2018, selling an estimated $5.72M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $2.14B portfolio in Q1 2018.
  • Eventide Asset Management opened 13 new positions and closed 10 in Q1 2018.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $2.14B.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.